Prana completes phase II trial with PBT2

Australia |  News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2013

Singapore: Prana Biotechnology announced the successful completion of Reach2HD, a phase II clinical trial in patients with early to mid-stage Huntington disease. The company expects to anno...Read more

Research at Peter Mac proves Cylene drug's efficacy

Australia |  News | By BioSpectrum Bureau | 0 Comment | 11 Jul, 2012

Singapore: Cylene Pharmaceuticals' research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia, have established, for the first time, that RNA Polymerase...Read more

Indian researcher named Woman of the Year in NSW

Australia |  News | By BioSpectrum Bureau | 0 Comment | 18 Mar, 2015

Singapore: Dr Minoti Apte, a 56-year-old pancreatic researcher from India, has been named as the New South Wales 'Woman of the Year' 2015 for her excellent contributions to medical research...Read more

Insulin sensitizer to treat diabetes

Australia |  News | By BioSpectrum Bureau | 0 Comment | 26 Mar, 2012

While pharmaceutical companies worldwide are looking for newer and safer insulin sensitizers to treat diabetes, Australia-based Verva Pharmaceuticals is working on a product candidate that ...Read more

BioSpectrum announces the hits and misses of 2013

Australia |  Analysis | By BioSpectrum Bureau | 0 Comment | 02 Jan, 2014

Asia attracted a lot of interest from foreign multinational giants in the year 2013. This not only led to the increase in the number of acquisitions and mergers (M&A), it also led to a ...Read more

Cellmid gets positive data in midkine study

Australia |  News | By BioSpectrum Bureau | 0 Comment | 23 Jan, 2013

Singapore: Cellmid has completed its first in-life diabetic nephropathy study with the company's anti-midkine antibodies (MKAb) in a mouse model of the disease. Two of Cellmid's proprietar...Read more

Paradigm gets US patent for bone marrow drug

Australia |  News | By BioSpectrum Bureau | 0 Comment | 26 Aug, 2015

Singapore: Australia based Paradigm Biopharmaceuticals has been granted a patent by United States Patent and Trademark Office (USPTO) to use the drug Pentosan Polysulphate Sodium (PPS) for ...Read more

China's Yabao pharma inks deal with Australian University

Australia |  News | By BioSpectrum Bureau | 0 Comment | 09 Sep, 2015

Singapore: China's leading pharmaceutical firm Yabao Pharmaceutical has inked a pact with the University of South Australia, to develop new treatments for cancer.Under the terms of the deal...Read more

Queensland health officials fear measles outbreak

Australia |  News | By BioSpectrum Bureau | 0 Comment | 20 Jun, 2014

Singapore: With rising measles cases in Queensland, Australian health authorities fear a severe outbreak, as 41 cases have been reported so far in the country. The health officials said tha...Read more

Australian tropical research receives $15.4 mn boost

Australia |  News | By BioSpectrum Bureau | 0 Comment | 15 May, 2015

Singapore: In a bid to foster the burgeoning tropical medicine sector in the country, the Australian government has announced funding assistance of $15.4 million to further bolster and acce...Read more

Bionomics to initiate trial for antibody targeting cancer stem cell

Australia |  News | By BioSpectrum Bureau | 0 Comment | 31 Aug, 2015

Singapore: Bionomics, Australia based biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of diseases of the central nervous syst...Read more

Aussie cell generation technology gets US patent

Australia |  News | By BioSpectrum Bureau | 0 Comment | 13 May, 2015

Singapore: Australia based Avita Medical, a regenerative medicine company specializing in the treatment of wounds and skin defects, has recieved US patent for its method of making and using...Read more

ResMed to sell sleep technology in UK

Australia |  News | By BioSpectrum Bureau | 0 Comment | 15 May, 2015

Singapore: Australian respiratory technology company Rhinomed has formed a sales agreement with global sleep technology firm, ResMed, to distribute and sell Mute snoring reduction and sleep...Read more

Biocryst licenses flu drug to CSL in a $45 million deal

Australia |  News | By BioSpectrum Bureau | 0 Comment | 19 Jun, 2015

Singapore: Biocryst Pharmaceuticals has inked a $45 million deal with Australia's CSL licensing the rights to its influenza drug (permavir) to CSL. The deal will help Biocryst focus entirel...Read more

Australian instrumental in merging Asian science academies

Australia |  News | By BioSpectrum Bureau | 0 Comment | 23 Oct, 2012

Singapore: Science in Asia will be more visible and effective under a merger between the two groupings of Asian science academies, facilitated over several years with leadership from the Au...Read more

Telstra health expands Asia presence

Australia |  News | By BioSpectrum Bureau | 0 Comment | 26 Aug, 2015

Singapore: Australia's largest telecommunication and technology company, Telstra health, announced several key contract wins and implementations of hospital electronic medical record system...Read more

Telstra acquires UK-based healthcare firm

Australia |  News | By BioSpectrum Bureau | 0 Comment | 27 Mar, 2015

Singapore: Australia-based Telstra healthcare has recently acquired a UK-based health analytics company, Dr Foster in a deal estimated to be worth between $40 million to $50 million. In add...Read more

A re-think on site staff competency training required

Australia |  Opinion | By BioSpectrum Bureau | 0 Comment | 05 Sep, 2013

When drugs are trialed in patients, they move into a clinical setting in which the busy routine care of patients, rather than the conduct of drug trials, is usually the main preoccupation...Read more